+7 495 258-34-28
Private office +7 495 258-34-28
Back to the list of publications

Pharmaceutical company FC Grand Capital is No.171 in RBC's 500 largest Russian companies by revenue.

18 november 2021

RBC has published the latest edition of its annual ranking of Russia's 500 largest companies (RBC500) for 2020. The company's net revenue amounted to RUB 86 billion, up 39% from the previous period. This placed FC Grand Capital at number 171, improving its position by 44 points (215th in the RBC500 ranking for 2019).

"Today we can confidently say that, given the company's development dynamics, efficiency of operations and implementation of modern business process technologies, FC Grand Capital will continue its steady advance in the rankings. The RAEX-600 rating 'Russia's Largest Companies by Sales Volume' was also recently published, where FC Grand Capital has moved up 59 positions," said General Director Denis Remenyako.

The rating's objectives are to identify Russia's largest companies, identifying their affiliation by industry and identifying trends in economic processes taking place in sectors of the Russian economy. The main indicator for ranking companies is their revenues net of VAT, excise duties and export duties. In the RBC 500 ranking, only Russian companies are given numbered positions.

Learn more: https://pro.rbc.ru/rbc500  

9 december 2021

On 9 December 2021, the pharmaceutical company Avexima JSC and Moscow Region Development Corporation JSC signed an additional agreement...

7 october 2021
The main criterion is the volume of production sold in the previous year.